Regarding lymphocyte subsets, CD4+ lymphopenia was observed in 34.5% of patients with BRAF mutations, whereas only 9.1% of MAP2K1-mutated individuals exhibited this finding. The gene discussed is MAP2K1; the disease is lymphopenia.